Lvxi Cimi Di Wan (氯烯雌醚滴丸)氯烯雌醚滴丸
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 苏州第壹制药有限公司Chinese legal name: 苏州第壹制药有限公司
主要成分Active Ingredients
- 其化学名为Qihua Xueming Wei
药物知识说明
其化学名为是一种在国家药监局注册认定的药品。该药品含有其化学名为-9702a577等成分。
该药品关联的活性成分包括：其化学名为。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：苏州第壹制药有限公司Chinese legal name: 苏州第壹制药有限公司。
您可以探索含有相同成分的其他药品：其化学名为-9702a577成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氯烯雌醚滴丸) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 苏州第壹制药有限公司Chinese legal name: 苏州第壹制药有限公司.
Explore other medicines containing the same ingredient: 其化学名为 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氯烯雌醚滴丸Recorded Chinese name: 氯烯雌醚滴丸
- 剂型Dosage form: 滴丸剂Recorded Chinese dosage form
- 规格Specification: 4mg4 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 苏州第壹制药有限公司Chinese legal name: 苏州第壹制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32023059
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32023059
Manufacturer
Chinese legal name: 苏州第壹制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32023059
生产企业
苏州第壹制药有限公司(国产)
适应症
用于治疗妇女更年期综合征及手术后因雌激素缺乏所引起的症状；青春期功能失调性子宫出血；妇女性腺功能不全的雌激素替代治疗；男性前列腺增生。
用法用量
口服 1.妇女更年期综合征及手术后因雌激素缺乏所引起的症状：每日剂量4~12mg，每20~22天为一疗程，停药后7天，再开始另一疗程，症状改善后，剂量可逐渐减少。 2.青春期功能失调性子宫出血：每日剂量20~80mg，分2~3次服用，止血后酌情递减，每日维持量8mg。 3.妇女性腺功能不全：每日剂量8~12mg，连服21日，停药7日再服。可按个人情况增减。 4.前列腺增生：每日剂量12~24mg，4~8周为一疗程，必要时可延长或遵医嘱。
不良反应
偶见轻微胃部不适、恶心、呕吐、头晕、乳房胀痛、阴道出血、嗜睡、尿频、尿痛、头痛、腹痛、胸痛、皮疹等。
禁忌
诊断未明确的妇科出血，有胆汁郁积性黄疸病史，血栓病史，乳癌及怀疑与雌激素有关的肿病患者禁用。
注意事项
1.下列情况慎用：哮喘、心功能不全、癫痫、精神抑郁、偏头痛、肾肝功能异常、良性乳房病、子宫肌瘤、高血压、冠心病、糖尿病、子宫内膜异位症、胆石症、高血钙合并肿瘤或骨代谢病等。
2.对诊断的干扰：
(1)去甲肾上腺素促进血小板凝集实验。
(2)BSP潴留增加。
(3)血清结合T4增加、T3下降。
(4)抗凝血酶Ⅲ、VB6排泄，血清叶酸含量下降。
3.用药期间应注意检查：血压、肝功能、巴氏（papanicolaon）涂片检查，每6~12个月进行妇科检查。
贮藏
密封，置阴凉处。
规格
4mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.